Moneyta · stock research · no sign-up needed
RMD
FollowFigures below come straight from SEC filings: every number is the company's own, on the record.
Revenue (Q3 FY2026)
$1.4B
+10.8% y/y
Net income (Q3 FY2026)
$399M
as filed with the SEC
Institutions holding
895
-54 last quarter
Overview · RESMED INC
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic pr…
Management team
- Mr. Kaushik Ghoshal · Chief Commercial Officer - SaaSFind on LinkedIn
- Mr. Alastair Robertson · Chief Information OfficerFind on LinkedIn
- Mr. Justin Leong · Chief Product OfficerFind on LinkedIn
- Mr. Michael J. Rider · Chief Legal Officer & SecretaryFind on LinkedIn
Start free to see the full management team.
Links open LinkedIn searches, not verified profiles. Team data from our market-data vendor's company profile.
What history says when its signals fire
Every signal Moneyta surfaces carries its full base-rate history: how often it beat the index, and how often it didn't. See the evidence
The desk's Snapshot
3 of 15 open to everyone · members see allRead the full desk report on RMD
Seven analysts, the debate, the risk review, every claim cited. And the same for every name you hold.
Free plan, no credit card required. Silver opens the full report, $19.99 a month. AI-written · every claim cites a source · Insight, not advice.
The full desk report
Seven AI analysts read the filings and argue both sides. What survives, with every claim cited, for members.
Who holds it, who's buying Gold
Full holder table, quarter-over-quarter flows, insider transactions, and the conviction screen.
Largest holder
Net flow last quarter
Insider buys, 90d
Further reading
Source: SEC EDGAR (XBRL company facts, form 13F-HR). Educational analysis of published data: insight, not advice.